全文获取类型
收费全文 | 15601篇 |
免费 | 1385篇 |
国内免费 | 8篇 |
出版年
2021年 | 204篇 |
2020年 | 104篇 |
2019年 | 175篇 |
2018年 | 157篇 |
2017年 | 137篇 |
2016年 | 305篇 |
2015年 | 519篇 |
2014年 | 564篇 |
2013年 | 791篇 |
2012年 | 918篇 |
2011年 | 953篇 |
2010年 | 619篇 |
2009年 | 576篇 |
2008年 | 823篇 |
2007年 | 840篇 |
2006年 | 746篇 |
2005年 | 807篇 |
2004年 | 767篇 |
2003年 | 730篇 |
2002年 | 708篇 |
2001年 | 214篇 |
2000年 | 181篇 |
1999年 | 203篇 |
1998年 | 208篇 |
1997年 | 136篇 |
1996年 | 144篇 |
1995年 | 121篇 |
1994年 | 113篇 |
1993年 | 120篇 |
1992年 | 142篇 |
1991年 | 142篇 |
1990年 | 122篇 |
1989年 | 97篇 |
1988年 | 127篇 |
1987年 | 123篇 |
1986年 | 125篇 |
1985年 | 116篇 |
1984年 | 150篇 |
1983年 | 131篇 |
1982年 | 148篇 |
1981年 | 159篇 |
1980年 | 160篇 |
1979年 | 130篇 |
1978年 | 126篇 |
1977年 | 133篇 |
1976年 | 110篇 |
1975年 | 108篇 |
1974年 | 130篇 |
1973年 | 93篇 |
1969年 | 83篇 |
排序方式: 共有10000条查询结果,搜索用时 62 毫秒
1.
Based on its proven anabolic effects on bone in osteoporosis patients, recombinant parathyroid hormone (PTH1-34) has been evaluated as a potential therapy for skeletal repair. In animals, the effect of PTH1-34 has been investigated in various skeletal repair models such as fractures, allografting, spinal arthrodesis and distraction
osteogenesis. These studies have demonstrated that intermittent PTH1-34 treatment enhances and accelerates the skeletal repair process via a number of mechanisms, which include effects on mesenchymal
stem cells, angiogenesis, chondrogenesis, bone formation and resorption. Furthermore, PTH1-34 has been shown to enhance bone repair in challenged animal models of aging, inflammatory arthritis and glucocorticoid-induced
bone loss. This pre-clinical success has led to off-label clinical use and a number of case reports documenting PTH1-34 treatment of delayed-unions and non-unions have been published. Although a recently completed phase 2 clinical trial of PTH1-34 treatment of patients with radius fracture has failed to achieve its primary outcome, largely because of effective healing
in the placebo group, several secondary outcomes are statistically significant, highlighting important issues concerning the
appropriate patient population for PTH1-34 therapy in skeletal repair. Here, we review our current knowledge of the effects of PTH1-34 therapy for bone healing, enumerate several critical unresolved issues (e.g., appropriate dosing regimen and indications)
and discuss the long-term potential of this drug as an adjuvant for endogenous tissue engineering. 相似文献
2.
3.
4.
Edward Harrison 《BMJ (Clinical research ed.)》1916,1(2888):645-647
5.
Transcriptional regulatory network triggered by oxidative signals configures the early response mechanisms of japonica rice to chilling stress 总被引:3,自引:0,他引:3
6.
I Djajanegara R Holtzapffel P M Finnegan M H Hoefnagel D A Berthold J T Wiskich D A Day 《FEBS letters》1999,454(3):220-224
The alternative oxidase is a quinol oxidase of the respiratory chain of plants and some fungi and protists. Its activity is regulated by redox-sensitive disulphide bond formation between neighbouring subunits and direct interaction with certain alpha-ketoacids. To investigate these regulatory mechanisms, we undertook site-directed mutagenesis of soybean and Arabidopsis alternative oxidase cDNAs, and expressed them in tobacco plants and Escherichia coli, respectively. The homologous C99 and C127 residues of GmAOX3 and AtAOX1a, respectively, were changed to serine. In the plant system, this substitution prevented oxidative inactivation of alternative oxidase and rendered the protein insensitive to pyruvate activation, in agreement with the recent results from other laboratories [Rhoads et al. (1998) J. Biol. Chem. 273, 30750-30756; Vanlerberghe et al. (1998) Plant Cell 10, 1551-1560]. However, the mutated protein is instead activated specifically by succinate. Measurements of AtAOX1a activity in bacterial membranes lacking succinate dehydrogenase confirmed that the stimulation of the mutant protein's activity by succinate did not involve its metabolism. Examples of alternative oxidase proteins with the C to S substitution occur in nature and these oxidases are expected to be activated under most conditions in vivo, with implications for the efficiency of respiration in the tissues which express them. 相似文献
7.
8.
9.
10.
Ralf Heinrich Peter Bräunig Ismeni Walter Henning Schneider Edward A. Kravitz 《Journal of comparative physiology. A, Neuroethology, sensory, neural, and behavioral physiology》2000,186(7-8):617-629
In the American lobster (Homarus americanus) the biogenic amines serotonin and octopamine appear to play important and opposite roles in the regulation of aggressive behavior, in the establishment and/or maintenance of dominant and subordinate behavioral states and in the modulation of the associated postural stances and escape responses. The octopamine-containing neurosecretory neurons in the thoracic regions of the lobster ventral nerve cord fall into two morphological subgroups, the root octopamine cells, a classical neurohemal group with release regions along second thoracic roots, and the claw octopamine cells, a group that selectively innervates the claws. Cells of both subgroups have additional sets of endings within neuropil regions of ganglia of the ventral nerve cord. Octopamine neurosecretory neurons generally are silent, but when spontaneously active or when activated, they show large overshooting action potentials with prominent after-hyperpolarizations. Autoinhibition after high-frequency firing, which is also seen in other crustacean neurosecretory cells, is readily apparent in these cells. The cells show no spontaneous synaptic activity, but appear to be excited by a unitary source. Stimulation of lateral or medial giant axons, which excite serotonergic cells yielded no response in octopaminergic neurosecretory cells and no evidence for direct interactions between pairs of octopamine neurons, or between the octopaminergic and the serotonergic sets of neurosecretory neurons was found. 相似文献